do you take that guy seriously, any tom dick and harry can come...

do you take that guy seriously, any tom dick and harry can come in and trash a beaten stock, it takes guts and research to be provide actual research materials otherwise, as I mentioned before, he lost quiet a bit during the 0.6 ish event , he got greedy and lost a lot of upside and went to RAC and lost half of his investment and now is short on IMU, now why I am excited with this

1. PD1-Vaxx remains a first-in-class attempt at replacing expensive and recurring antibody therapy
2. Unique PD-1 vaccine; no approved PD-1 vaccines exist yet
3. Used to Evaluate major pathological response (tumour shrinkage pre-surgery), means no ethical issue here, still it will work with standard care, its used pre surgery.
4. Potential Expansion to broader solid tumour indications, depending on efficacy data in CRC.

I am not sure why this is not price sensitive, but looks like IMU are scared that shorters may try to push this down delibrately I am not sure I should be exited and buy more or wait for few more news to roll out...